Taken together, our data reveal an involvement of HDACs 1 and 2 in NF-κB-dependent transcription repression of Sox18 and suggest a potential therapeutic application of HDAC1/2 inhibitors in ALI/ARDS. The gene discussed is HDAC1; the disease is acute respiratory distress syndrome.